medi USA Launches New circaid® profile Foam Sleeve for Lymphedema

medi USA announced the launch of the new circaid® profile foam sleeve for lymphedema management at-home. The circaid profile foam sleeve is an alternative or supplement to nighttime and home-care bandaging applications that applies gradient compression to the affected limb or limbs.

Video here.

Engineered with first-use foam for hygenic confidence and brrr® cooling fabric proven to keep patients cooler, the circaid profile allows wearers to manage their own therapy comfortably at home. The foam creates a massaging effect and promotes continuous airflow, and with an anatomic fit, the sleeve provides full limb coverage. Included standard is an energy oversleeve available in four color choices that provides added compression for maximum effect, an EZ-on system that easily applies the sleeve and the profile anchor system to help keep the compressive oversleeve in place.

“The profile showcases medi’s commitment to quality and passion for originality and innovation. From the project start, there was an all hands-on deck approach and shared enthusiasm to breathe new life into a familiar concept,” said Moses Lipshaw, Director of Research & Development at medi USA. “With simplified donning, cooling comfort, long-lasting compression and premium features, patients will benefit from a new standard in padded night care.”

The brrr® Triple Chill Effect included in the circaid profile foam sleeve has three unique cooling effects  – cooling minerals, rapid drying and active wicking – that continually enhance comfort and reduce the temperature of the skin.

The circaid profile foam sleeve offers the widest ready-to-wear size range in the market with 16 sizes and 2 lengths, and it has a 30-day fit guarantee. For easy ordering, the profile uses the same size chart as the mediven® harmony and comfort arm sleeves. Along with the ready-to-wear option, it is also available in custom-made sizing and includes a 1-year the New You! guarantee for a one-time, free reduction alteration to reward patients who succeed in their treatment plan.

The new circaid profile joins a full range of compression products offered by medi in their circaid inelastic compression line, inspired by nature. medi creates compression products that fit every patient for all stages of venous and lymphatic conditions.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.